- Aarti Pharmalabs
Aarti Pharmalabs Share Price
NSE: AARTIPHARM
|BSE: 543748
|Pharmaceuticals
₹853.30
-₹19.65 (-2.25%) Last updated on 24 Jun, 2025 | 10:11 ISTAarti Pharmalabs Overview
Market cap  ₹7,733 Crs | Open ₹884.00 | Prev. Close ₹872.95 |
Circuit range ₹1,047.50 - ₹698.40 | Day range ₹845.15 - ₹884.50 | Year range ₹551.05 - ₹949.50 |
Volume 1,32,781 | Avg. traded ₹861.06 | Revenue (12m) ₹2,115 Crs |
About Aarti Pharmalabs
Aarti Pharmalabs Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, and xanthine derivatives, based in India. The Company also offers comprehensive contract development and manufacturing organization (CDMO) and CMO services for drug substances and new chemical entities (NCE), including their key starting materials (KSM) and regulatory starting materials (RSM), serving various pharmaceutical companies worldwide with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products. Its caffeine products include caffeine anhydrous, and caffeine anhydrous (granules). Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. Its products are exported to key regulated markets such as the United States (US), the European Union, and Japan.
Aarti Pharmalabs Share Price Chart
Please wait...
Aarti Pharmalabs Key Indicators
P/E ratio 28.39 | P/B ratio 4.21 | ROE 13.11% |
ROCE 16.55% | Dividend yield 0.54% | Debt/Equity ratio 0.15 |
EPS 22.14 |
Investment Checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Aarti Pharmalabs Financial Ratios
Operating profit margin23.78% | Net profit margin13.36% |
ROE13.11% | ROA9.39% |
ROCE16.55% |
Quick ratio0.99 | Current ratio2.04 |
Interest coverage17.5 | Asset turnover0.7 |
Debt to Equity0.15 |
P/E ratio28.39 | P/B ratio4.21 |
EV / EBITDA11.73 | |
Dividend yield0.54% |
Revenue Statement
All values are in ₹ Crores (Cr)
Year  | Revenue  | Operating Profit | Net Profit |
|---|---|---|---|
Mar-24 | ₹1,852.61 | ₹390.94 | ₹216.90 |
Mar-23 | ₹1,945.23 | ₹344.37 | ₹193.49 |
Mar-22 | ₹1,199.94 | ₹209.46 | ₹122.25 |
Mar-21 | ₹0.00 | ₹0.00 | ₹0.00 |
Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
|---|---|---|---|
Mar-24 | ₹-214.56 | ||
Mar-23 | ₹-157.8 | ₹-163.47 | |
Mar-22 | ₹-43.7 | ₹-138.74 | |
Mar-21 | ₹0.00 | ₹0.00 | ₹0.00 |
Balance Sheet
All values are in ₹ Crores (Cr)
Period | Total Asset | Total Liability |
|---|---|---|
Mar-24 | ₹2,582.11 | ₹825.07 |
Mar-23 | ₹2,244.02 | ₹685.54 |
Mar-22 | ₹2,039.90 | ₹653.42 |
Mar-21 | ₹0.25 | ₹0.02 |
Aarti Pharmalabs Share Price History
| Day | Open | Close | Change % |
|---|---|---|---|
23-Jun-25 | ₹849.80 | ₹872.95 | |
20-Jun-25 | ₹846.75 | ₹853.25 | |
19-Jun-25 | ₹880.90 | ₹842.50 | -4.35% |
18-Jun-25 | ₹863.45 | ₹880.80 | |
17-Jun-25 | ₹874.40 | ₹859.20 | -1.73% |
16-Jun-25 | ₹890.00 | ₹874.35 | -1.28% |
13-Jun-25 | ₹910.00 | ₹885.65 | -3.56% |
12-Jun-25 | ₹921.40 | ₹918.30 |
Corporate Actions
Dividend • ₹2.5/share
Ex date 14 Feb 2025
Dividend • ₹1/share
Ex date 31 Jul 2024
Dividend • ₹2/share
Ex date 16 Feb 2024
Popular Stocks
Stock Name | Price | Change % |
|---|---|---|
| Aarti Industries | ₹461.25 | +₹16.10 (3.62%) |
| HDFC Bank | ₹1,971.00 | +₹22.60 (1.16%) |
| Indian Railway Tourism Corp | ₹766.45 | +₹8.60 (1.13%) |
| Infosys | ₹1,597.60 | +₹13.60 (0.86%) |
| ITC | ₹418.20 | +₹4.30 (1.04%) |
| JIO FIN SERVICES LTD | ₹301.00 | +₹7.85 (2.68%) |
| Reliance | ₹1,470.50 | +₹13.70 (0.94%) |
| Tata Motors | ₹681.90 | +₹10.65 (1.59%) |
| Tata Power | ₹396.80 | +₹3.80 (0.97%) |
| Wipro | ₹267.70 | +₹4.46 (1.69%) |
Aarti Pharmalabs News
Moneycontrol
AARTIPHARM Standalone March 2025 Net Sales at Rs 529.62 crore
Moneycontrol
AARTI PHARMA Consolidated March 2025 Net Sales at Rs 563.78 crore
Livemint
Breakout stocks to buy or sell: Sumeet Bagadia recommends seven shares!
Livemint
Despite stock market crash, these five stocks rise up to 35% in one month
Moneycontrol
AARTIPHARM Consolidated December 2024 Net Sales at Rs 537.78 crore
CNBC Television
Aarti Pharmalabs shares fall 5% from day's high
ET
Just smallcap stocks offer double-digit returns in flattish market
Livemint
Block Deal: Sunil Singhania’s Abakkus Asset Manager buys 1.18% stake
FAQs on Aarti Pharmalabs
What is the share price of Aarti Pharmalabs today?
Aarti Pharmalabs share price is ₹ 853.30 as on 24 Jun, 2025 | 10:11 IST.
What are the high & low stock price of Aarti Pharmalabs today?
Aarti Pharmalabs stock price hit a high of ₹ 884.50 and low of ₹ 845.15 as on 24 Jun, 2025 | 10:11 IST.
What is the market cap of Aarti Pharmalabs?
The market cap of Aarti Pharmalabs is ₹ 7,733.40 Crores as on 24 Jun, 2025 | 10:11 IST.
What are the the 52-week high and low share prices of Aarti Pharmalabs stock on the NSE?
52-week high stock Price of Aarti Pharmalabs is ₹ 949.50 and Low Price is ₹ 551.05 as on 24 Jun, 2025 | 10:11 IST.
What are the stock symbols of Aarti Pharmalabs?
The stock symbol of Aarti Pharmalabs is NSE: AARTIPHARM on the NSE, BSE: 543748 on the BSE, and the ISIN is INE0LRU01027.
Can I buy Aarti Pharmalabs shares on Holidays?
No, shares of Aarti Pharmalabs or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Aarti Pharmalabs shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Aarti Pharmalabs?
The PE and PB ratio of Aarti Pharmalabs is 28.39 and 4.21 respectively, as on 24 Jun, 2025 | 10:11 IST.
What are the returns on Aarti Pharmalabs shares?
The historical returns for Aarti Pharmalabs shares are 35.55 for 1 year, 196.01 for 3 year and 196.01 for 5 year.